This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
A vial of a plant-derived COVID-19 vaccine candidate, developed by Medicago, is shown in this handout photo taken in Quebec City on July 13, 2020. The Canadian Press/HO, Medicago
The federal government has recovered $40 million of its investment in the now-defunct, Quebec-based, vaccine developer, Medicago as part of a deal with the parent company, the innovation minister announced Dec. 7.
Medicago’s intellectual property will remain in Canada under a new firm as part of the agreement.
